Publications

by | May 31, 2015 | Uncategorized

WHA adopts resolutions on AMR and immunization

On 25 May 2015, the 68th World Health Assembly (WHA) – the supreme decision-making body of WHO which convenes annually in Geneva – agreed resolutions to tackle antimicrobial resistance and improve access to affordable vaccines.

Tackling antimicrobial drug resistance

The global importance and seriousness of AMR was highlighted by German Chancellor Angela Merkel, who told delegates on the opening day that addressing AMR is one of the highest health priorities for the world.

Following a request at the 2014 assembly to develop a draft plan, the WHA endorsed a Global Action Plan to tackle antimicrobial resistance (AMR) – including antibiotic resistance, the most urgent drug resistance trend worldwide.

The Global Action Plan sets out 5 objectives:

– improve awareness and understanding of antimicrobial resistance;
– strengthen surveillance and research;
– reduce the incidence of infection;
– optimize the use of antimicrobial medicines; and
– ensure sustainable investment in countering antimicrobial resistance.

The resolution urges Member States to put the plan into action, adapting it to their national priorities and specific contexts and mobilising additional resources for its implementation. Within two years, governments are requested to draw up national action plans on AMR in line with the global plan, i.e. covering animal health and agriculture, as well as human health. WHO will work with countries to support the development and implementation of their national plans and will report progress to the Health Assembly in 2017.

As EPHA has also underlined in its Position on AMR, without responsible prescribing, dispensing and prudent use of antibiotics, resistance to antibiotics will not be able to be contained.

Immunization

The WHA also agreed a resolution to improve access to sustainable supplies of affordable vaccines – a key issue for low- and middle-income countries aiming to extend immunization to the entire population. Already in 2012, a Global Vaccine Action Plan was adopted to ensure access to immunization by 2020, however WHO’s Strategic Advisory Group of Experts on immunization has cautioned that progress towards the Action Plan’s targets is slow and uneven.

The resolution calls on WHO to coordinate efforts to address gaps in progress. Crucially, it urges Member States to increase transparency around vaccine pricing and explore pooling the procurement of vaccines. It requests the WHO Secretariat to report on barriers that may undermine robust competition that can enable price reductions for new vaccines, and to address any other factors that might adversely affect availability. The resolution also highlights that immunization is a highly cost-effective public health intervention, playing a major role in reducing child deaths and improving health. It recommends scaling up advocacy efforts to improve understanding of the value of vaccines and to allay fears leading to vaccine hesitancy.

—-
Related articles:
-[->5919]
-[->5857]
-[->5133]
-[->3703]

Get the EPHA Newsletter

The best of our activities, right in your inbox!